How should we treat Crohn's disease?
D000305:Adrenal Cortex Hormones / Q000008:administration & dosage / Q000627:therapeutic use; D000328:Adult; D001379:Azathioprine / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D003424:Crohn Disease / Q000188:drug therapy*; D004311:Double-Blind Method; D004359:Drug Therapy, Combination; D006801:Humans; D015122:Mercaptopurine / Q000008:administration & dosage / Q000627:therapeutic use; D010195:Pancreatitis / Q000139:chemically induced; D010919:Placebos; D011241:Prednisone / Q000627:therapeutic use; D011897:Random Allocation; D012075:Remission, Spontaneous; D012460:Sulfasalazine / Q000627:therapeutic use; D013997:Time Factors
D000305:Adrenal Cortex Hormones; D010919:Placebos; D012460:Sulfasalazine; D015122:Mercaptopurine; D001379:Azathioprine; D011241:Prednisone